Concepedia

Kei Yamamoto

KY

25

Publications

1.9K

Citations

21

H-Index

1995

Active since

Affiliations

Tokyo Metropolitan Institute of Medical Science(Current)

Tokushima University

Japan Agency for Medical Research and Development

Japan Science and Technology Agency

The University of Osaka

Kei Yamamoto is an author at Tokyo Metropolitan Institute of Medical Science specializing in medicine, signal transduction, and cell signaling.

ORCID

Top concepts

Publications per year

1995–2022

25

Publications

25

A new era of secreted phospholipase A2

Makoto Murakami, Hiroyasu Sato, Yoshimi Miki et al. · Journal of Lipid Research · 2015 · 222 citations · Full text

Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist

Natsuo Ueda, Kei Yamamoto, Shozo Yamamoto et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1995 · 165 citations

, , +5

Phosphorylation of p38 Mitogen-Activated Protein Kinase Downstream of Bax-Caspase-3 Pathway Leads to Cell Death Induced by High <scp>d</scp>-Glucose in Human Endothelial Cells

Hironori Nakagami, Ryuichi Morishita, Kei Yamamoto et al. · Diabetes · 2001 · 164 citations · Full text

Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome–CoV infection

Rahul Vijay, Xiaoyang Hua, David K. Meyerholz et al. · The Journal of Experimental Medicine · 2015 · 139 citations · Full text

Analyses of Group III Secreted Phospholipase A2 Transgenic Mice Reveal Potential Participation of This Enzyme in Plasma Lipoprotein Modification, Macrophage Foam Cell Formation, and Atherosclerosis

Hiroyasu Sato, Rina Kato, Yuki Isogai et al. · Journal of Biological Chemistry · 2008 · 130 citations · Full text

Rows per page

1–5 of 25